When the components of the postsynaptic compartment were investigated, we did not find any alterations in the levels of the postsynaptic density protein SH3 and multiple ankyrin repeat domains protein 2 and the dendritic marker MAP2 in AD (Fig. 3), which were in line with our previous proteomic findings.17 This evidence concerns the gene MAP2 and Alzheimer disease.